Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Marc S. Greenblatt, W P Bennett, Monica Hollstein et al. · PubMed · 1994 · 3.5K citations

Medicine, Genetics, Molecular Genetics +16

Cancer statistics, 1996

T. Tong, S. Bolden, Phyllis A. Wingo · CA A Cancer Journal for Clinicians · 1996 · 1.8K citations · Full text

Medicine, Biostatistics, Oncology +17

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Mark Redston, Carlos Caldas, Albert Seymour et al. · PubMed · 1994 · 458 citations

Medicine, Genetics, Oncology +15

K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

Natalia S. Pellegata, Fausto Sessa, Beatrice Renault et al. · PubMed · 1994 · 390 citations

Medicine, Molecular Genetics, Oncology +17

Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

Akio Yanagisawa, Keiko Ohtake, Kazuhiko Ohashi et al. · PubMed · 1993 · 356 citations

Medicine, Oncology, Pathology +17